Delek US Hldgs Analyst Ratings
Goldman Sachs Maintains Neutral on Delek US Hldgs, Lowers Price Target to $15
Morgan Stanley Maintains Underweight on Delek US Hldgs, Lowers Price Target to $14
Wells Fargo Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $11
Delek US Hldgs Analyst Ratings
Wells Fargo Maintains Underweight on Delek US Hldgs, Lowers Price Target to $11
BofA Securities Maintains Delek US(DK.US) With Sell Rating
TD Cowen Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $10
Scotiabank Maintains Delek US(DK.US) With Hold Rating, Cuts Target Price to $14
Raymond James Maintains Delek US(DK.US) With Buy Rating, Cuts Target Price to $23
UBS Maintains Delek US(DK.US) With Hold Rating, Cuts Target Price to $13.25
Raymond James Maintains Outperform on Delek US Hldgs, Lowers Price Target to $23
Delek US Is Maintained at Neutral by Mizuho
Delek US Hldgs Analyst Ratings
Mizuho Securities Maintains Delek US(DK.US) With Hold Rating, Cuts Target Price to $22
J.P. Morgan Maintains Delek US(DK.US) With Hold Rating, Raises Target Price to $20
Wells Fargo Maintains Delek US(DK.US) With Sell Rating, Raises Target Price to $16
Wells Fargo Sticks to Their Sell Rating for Delek US Holdings (DK)
Delek US Hldgs Analyst Ratings
Morgan Stanley Maintains Underweight on Delek US Hldgs, Lowers Price Target to $18